NO140269C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme cefalosporinderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme cefalosporinderivater

Info

Publication number
NO140269C
NO140269C NO3568A NO3568A NO140269C NO 140269 C NO140269 C NO 140269C NO 3568 A NO3568 A NO 3568A NO 3568 A NO3568 A NO 3568A NO 140269 C NO140269 C NO 140269C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically effective
cephalosporine derivatives
analogical procedure
analogical
Prior art date
Application number
NO3568A
Other languages
English (en)
Other versions
NO140269B (no
Inventor
Leonard Bruce Crast Jr
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO140269B publication Critical patent/NO140269B/no
Publication of NO140269C publication Critical patent/NO140269C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pyridine Compounds (AREA)
NO3568A 1967-01-05 1968-01-04 Analogifremgangsmaate for fremstilling av terapeutisk virksomme cefalosporinderivater NO140269C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60737867A 1967-01-05 1967-01-05

Publications (2)

Publication Number Publication Date
NO140269B NO140269B (no) 1979-04-23
NO140269C true NO140269C (no) 1979-08-01

Family

ID=24432009

Family Applications (1)

Application Number Title Priority Date Filing Date
NO3568A NO140269C (no) 1967-01-05 1968-01-04 Analogifremgangsmaate for fremstilling av terapeutisk virksomme cefalosporinderivater

Country Status (11)

Country Link
AT (1) AT276626B (no)
BE (1) BE709019A (no)
CH (1) CH487181A (no)
DE (1) DE1670301C3 (no)
DK (1) DK126595B (no)
FR (2) FR1580837A (no)
GB (1) GB1213571A (no)
IL (1) IL29235A (no)
NL (1) NL6800176A (no)
NO (1) NO140269C (no)
SE (1) SE349564B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758764A (fr) * 1969-11-13 1971-05-10 Bristol Myers Co Procede de preparation d'agents antibacteriens
US3631027A (en) * 1970-03-27 1971-12-28 Bristol Myers Co Cephalosporanic acids
CH648317A5 (de) 1977-06-10 1985-03-15 Yamanouchi Pharma Co Ltd 7alpha-methoxy-7betha-(1,3-dithietan-2- carboxamido)cephalosporansaeurederivate und verfahren zu ihrer herstellung.
JPS5854157B2 (ja) * 1977-06-10 1983-12-02 山之内製薬株式会社 セフアロスポリン化合物の新規誘導体ならびにその製造方法
IT1141406B (it) * 1980-04-01 1986-10-01 Dob Far Spa Sali della cefapirina con aminoacidi
GB2122603A (en) * 1982-06-25 1984-01-18 Lark Spa 7-Ä???-(substituted-thio)-acylamidoÜ-cephalosporanic acids
US6369049B1 (en) 1998-04-30 2002-04-09 Eli Lilly And Company Treatment of mastitis

Also Published As

Publication number Publication date
IL29235A (en) 1971-10-20
FR1580837A (no) 1969-09-12
BE709019A (no) 1968-07-05
FR8381M (no) 1971-03-01
SE349564B (no) 1972-10-02
CH487181A (de) 1970-03-15
DE1670301C3 (de) 1975-12-18
NO140269B (no) 1979-04-23
AT276626B (de) 1969-11-25
DE1670301A1 (de) 1972-02-24
DE1670301B2 (de) 1975-05-07
GB1213571A (en) 1970-11-25
DK126595B (da) 1973-07-30
NL6800176A (no) 1968-07-08

Similar Documents

Publication Publication Date Title
FI42712C (fi) Menetelmä terapeuttisesti vaikuttavien bifenyylialkaanijohdannaisten valmistamiseksi
NO781312L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-merkaptotiadiazol- eller merkaptotetrazol-cefalosporiner
NO139560C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
SE383887B (sv) Analogiforfarande for framstellning av alfa-amino-cyklohexadienyl-alkylen-penicilliner
SE382065B (sv) Forfarande for framstellning av linkomycinderivat
FI50119C (fi) Menetelmä uusien terapeuttisesti tehokkaiden N-(3-sulfamyyli-4-kloorib entsamido)-indoliinijohdannaisten valmistamiseksi.
SE394678B (sv) Analogiforfarande for framstellning av pyridokinolinderivat
NO140058C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO137824C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylalkyltetrazoler
DK134647C (da) Analogifremgangsmade til fremstilling af cephalosporinderivater eller terapeutisk acceptable salte deraf
NO140269C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme cefalosporinderivater
FI50410C (fi) Menetelmä tulehdusta estävien substituoitujen aminopyriinien valmistam iseksi
NO141807C (no) Fremgangsmaate for fremstilling av aktiv toerrgjaer
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO138375C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme cefalosporinderivater
NO137695C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-tienylmetyl-heterocykliske forbindelser
SE398232B (sv) Forfarande for framstellning av bensodiazepinderivat
SE343302B (sv) Foerfarande foer framstaellning av bensomorfanderivat
NO140103C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme penicilliner
SE343292B (sv) Foerfarande foer framstaellning av vissa angivna bensofenoniminer
SE343309B (sv) Foerfarande foer framstaellning av skumformiga etensampolymerisat
NO137964C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme norbornanderivater
NO138768C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-fenylacetamidocefalosporansyrederivater
SE333149B (sv) Foerfarande foer framstaellning av bensimidazol-n-oxider
SE381870B (sv) Forfarande for framstellning av vissa angivna terapeutiskt anvendbara butyramidiner